LENSAR Inc (LNSR)
6.06
+0.20
(+3.41%)
USD |
NASDAQ |
Nov 05, 09:38
LENSAR Enterprise Value: 53.81M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 53.81M |
| November 01, 2024 | 48.24M |
| October 31, 2024 | 51.72M |
| October 30, 2024 | 49.98M |
| October 29, 2024 | 49.05M |
| October 28, 2024 | 50.79M |
| October 25, 2024 | 47.31M |
| October 24, 2024 | 48.24M |
| October 23, 2024 | 50.79M |
| October 22, 2024 | 47.66M |
| October 21, 2024 | 49.87M |
| October 18, 2024 | 49.28M |
| October 17, 2024 | 53.00M |
| October 16, 2024 | 51.26M |
| October 15, 2024 | 45.80M |
| October 14, 2024 | 49.98M |
| October 11, 2024 | 41.86M |
| October 10, 2024 | 45.22M |
| October 09, 2024 | 40.81M |
| October 08, 2024 | 40.23M |
| October 07, 2024 | 37.10M |
| October 04, 2024 | 37.85M |
| October 03, 2024 | 37.44M |
| October 02, 2024 | 35.59M |
| October 01, 2024 | 36.86M |
| Date | Value |
|---|---|
| September 30, 2024 | 38.95M |
| September 27, 2024 | 37.33M |
| September 26, 2024 | 36.98M |
| September 25, 2024 | 37.21M |
| September 24, 2024 | 37.10M |
| September 23, 2024 | 36.52M |
| September 20, 2024 | 37.44M |
| September 19, 2024 | 35.82M |
| September 18, 2024 | 34.54M |
| September 17, 2024 | 34.54M |
| September 16, 2024 | 35.12M |
| September 13, 2024 | 44.53M |
| September 12, 2024 | 44.06M |
| September 11, 2024 | 43.25M |
| September 10, 2024 | 39.65M |
| September 09, 2024 | 40.35M |
| September 06, 2024 | 38.37M |
| September 05, 2024 | 37.56M |
| September 04, 2024 | 37.17M |
| September 03, 2024 | 39.53M |
| August 30, 2024 | 39.72M |
| August 29, 2024 | 39.77M |
| August 28, 2024 | 40.00M |
| August 27, 2024 | 39.77M |
| August 26, 2024 | 38.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.310M
Minimum
Nov 08 2023
87.04M
Maximum
Oct 05 2020
34.08M
Average
36.10M
Median
Enterprise Value Benchmarks
| Standard BioTools Inc | 468.31M |
| Ainos Inc | 9.488M |
| Zomedica Corp | 40.25M |
| Intelligent Bio Solutions Inc | 0.0571M |
| Adagio Medical Holdings Inc | 23.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.043M |
| Revenue (Quarterly) | 12.64M |
| Total Expenses (Quarterly) | 14.19M |
| EPS Diluted (Quarterly) | -0.79 |
| Gross Profit Margin (Quarterly) | 53.92% |
| Profit Margin (Quarterly) | -71.57% |
| Earnings Yield | -25.74% |
| Normalized Earnings Yield | -18.41 |